Clasp Therapeutics
PrivateLast Round
Series A
Mar 20, 2024
Total Funding Raised
$150M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Clasp Therapeutics is a biotechnology company developing next-generation T cell engagers that target tumor-specific oncogenic driver mutations for hard-to-treat cancers.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Clasp Therapeutics Comparables
Compare Clasp Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Cytospire Therapeutics | 81% | |
| CDR-Life | 81% | |
| Adaptin Bio | 76% |
Clasp Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Mar 20, 2024 |
Key People
Founding team and executive leadership
Clasp Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Catalio Capital Management | Series A |
| BrightEdge | Series A |
| Johns Hopkins University Endowment | Series A |
| Novo Holdings | Series A |
| Pictet Alternative Advisors | Series A |
| Alexandria Venture Investments | Series A |
| Cure Ventures | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors increased 58% MoM.
- Apr 28, 2025
Nonclinical data for CLSP-1025 presented at 2025 AACR Annual Meeting.
Clasp Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Clasp Therapeutics's valuation, stock price, and market status.
Is Clasp Therapeutics a public or private company?
Clasp Therapeutics is a private company.
What is the current stock price of Clasp Therapeutics?
Clasp Therapeutics is a private company with no public stock price. No recent secondary market data is available.
How much is Clasp Therapeutics worth (valuation)?
Valuation information for Clasp Therapeutics is not publicly available.
Can I buy Clasp Therapeutics stock?
Clasp Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Clasp Therapeutics's last funding round?
Clasp Therapeutics's most recent funding round was Series A on March 20, 2024.
Who are the main investors in Clasp Therapeutics?
Key investors in Clasp Therapeutics include Catalio Capital Management, Novo Holdings, Third Rock Ventures.
Will Clasp Therapeutics IPO soon?
No public IPO plans have been announced for Clasp Therapeutics.
How can I track Clasp Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Clasp Therapeutics's secondary market activity and sign up for updates.